We came across a bullish thesis on Novartis AG (NVS) on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on NVS. Novartis AG (NVS)’s share was trading at $120.77 as of 12th June. NVS’s trailing and forward P/E were 18.93 and 14.31 respectively according to Yahoo Finance.
A pharmaceutical sales rep holding a medicine pack, highlighting the drug candidate products.
Novartis presents a compelling long-term investment opportunity driven by...
